glp-1 and gip mechanism of action Dr.Syed GIP and GLP‐1, the two
Description
Drug therapy in obesity: a review of current and emerging treatments
It was great
Another report showed that sitagliptin (576 mg/kg) reduced plaque macrophage infiltration and matrix metallopeptidase-9 (MMP-9) levels in ApoE / mice [26] and increased activation of AMPK and AKT signaling pathway but inhibited MAPK and ERK1/2 signaling in aorta of ApoE / mice [66]
Safety: Both medicines can cause gastrointestinal side effects and need clinical review
Data were summarized with Mantel-Haenszel odds ratio (OR) with direct meta-analysis to compare the GLP-1 agonist group with the control group
They can prescribe anti-nausea medications or adjust your dose
